This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

17 Mar 2014

Optibrium and Integrated Chemistry Design Collaborat?e to Introduce Creative Compound Design on iPad

Optibrium and Integrated Chemistry Design, providers of software solutions and services for drug discovery, have announed the release of Asteris, a new iPad app that combines highly intuitive chemistry drawing tools with the most visually informative predictive modelling. Asteris enables creative researchers to rapidly evaluate new compound ideas when and where they want, no longer limited to sitting in an office or in front of a computer.


Asteris uses Chirys Draw’s patent pending chemical drawing tools, optimised specifically for the touch environment, allowing users to explore a much wider range of chemistry designs. Instant feedback from StarDrop’s predictive models, guided by the unique Glowing Molecule visualisation, dramatically reduces the time required to identify high quality compound designs. With Asteris  users can calculate a range of “core properties”, such as logP, molecular weight, polar surface area, and hydrogen bond donors, and predict over ten ADME properties, including solubility, hERG inhibition, and CNS penetration.


Dr Matthew Segall, Optibrium’s CEO, commented: “We are very pleased to be working with Integrated Chemistry Design. The combination of our unique technologies in Asteris provides an innovative ideas space, giving users the flexibility to explore new compound designs, beyond the constraints of traditional computational tools. This collaboration furthers our on-going strategy to work with other leading developers of innovative solutions for drug discovery.”


Dr M. Catherine Johnson, President and CEO of Integrated Chemistry Design added: “We are excited that Asteris provides medicinal chemists with powerful tools for evaluating prospective drug ideas, and they can use Asteris anywhere, in meetings or on travel as well as in their offices. Using Asteris, drug designers will be able to assess ideas more quickly to converge on the most promising candidates for further study.”


Asteris will be launched at the American Chemical Society Spring 2014 National Meeting & Expo in Dallas, Texas from 16–20 March (visit Optibrium, booth #1516) and Integrated Chemistry Design (booth #400) to see Asteris in action. From 16 March, Asteris can be downloaded from the App Store.

Related News